幽门螺杆菌社区筛查的效果:一项随机对照试验的13年随访评估
1998至1999年将20011名40至65岁个体随机分为幽门螺杆菌筛查根除组与无筛查对照组,13年后完成症状数据者8658人(69%)。筛查根除对消化不良患病率(调整OR 0.93,95%CI 0.82-1.04)、消化性溃疡发病率(调整OR 0.88,95%CI 0.70-1.11)、医疗资源使用及生活质量均无显著长期影响。
要点
- 在低患病率地区,幽门螺杆菌人群筛查根除对消化不良患病率无显著长期影响(调整OR 0.93,95%CI 0.82-1.04)。
- 筛查未显著降低消化性溃疡发病率(调整OR 0.88,95%CI 0.70-1.11),对医疗资源使用无有益影响。
- 筛查对生活质量无长期影响;意向性分析与符合方案分析结果相似。
核心结论
- 这项随访13年的随机临床试验显示,在低患病率地区,幽门螺杆菌人群筛查根除与常规诊疗相比无显著长期效果。
研究设计与样本
- 1998至1999年基线时,将20011名40至65岁个体随机分为幽门螺杆菌筛查根除组或无筛查对照组,两组均接受消化不良与生活质量问卷,并获取所有随机个体的登记数据。
主要发现
- 基线问卷应答率为63%;筛查的5749人中1007人(17.5%)幽门螺杆菌阳性。
- 13年后获得8658人(69%)的完整症状数据;随访期间两组消化不良患病率均下降,但多因素分析显示筛查根除无效果(调整OR 0.93,95%CI 0.82-1.04)。
- 登记数据的意向性分析与符合方案分析结果相似。
- 筛查既未显著降低消化性溃疡发病率(调整OR 0.88,95%CI 0.70-1.11),对医疗资源使用也无有益影响。
- 筛查对生活质量无长期影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Helicobacter pylori eradication improves the prognosis of peptic ulcer disease (PUD), dyspepsia, and possibly gastric cancer. H pylori screening tests are accurate and eradication therapy is effective. H pylori population screening seems attractive. The aim of this study was to evaluate the long-term effect of H pylori population screening and eradication on dyspepsia prevalence and the incidence of PUD, and as secondary outcomes to assess the effect on health care consumption and quality of life. METHODS: At baseline in 1998 to 1999, 20,011 individuals aged 40 to 65 years were randomized to H pylori screening and eradication or a control group with no screening. Both groups received a questionnaire on dyspepsia and quality of life. Register data were obtained for all randomized individuals. RESULTS: The baseline questionnaire response rate was 63%. Of the 5749 individuals screened, 1007 (17.5%) were H pylori positive. Complete symptom data were obtained for 8658 (69%) individuals after 13 years. Dyspepsia prevalence decreased in both groups during the follow-up period, but multivariate analysis showed no effect of H pylori screening and eradication (adjusted odds ratio, 0.93; 95% confidence interval, 0.82-1.04); compared with usual care. Intention-to-treat and per-protocol analyses of register data provided similar results. H pylori screening neither reduced PUD incidence significantly (adjusted odds ratio, 0.88; 95% confidence interval, 0.70-1.11) nor did it have a beneficial effect on health care consumption. H pylori screening had no long-term effect on quality of life. CONCLUSIONS: This randomized clinical trial with 13 years of follow-up evaluation, designed to provide evidence on the effect of H pylori population screening, showed no significant long-term effect when compared with usual care in this low-prevalence area. ClinicalTrials.gov identifier: NCT02001727.
引用
- Bomme M, Hansen JM, Wildner-Christensen M, et al. Effects of Community Screening for Helicobacter pylori: 13-Year Follow-Up Evaluation of a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2017. PMID: 28606845. doi:10.1016/j.cgh.2017.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。